FDA Nod Sends KAZIA Therapeutics Share Price Higher (ASX:KZA)
The share price of oncology-focused biotech firm, KAZIA Therapeutics Ltd [ASX:KZA], soared this morning on the receipt of FDA designation for its brain cancer treatment. At time of writing the KZA share price is up 26 cents or 46.43%, trading at 82 cents per share.





